Hjem › Eggstokkreft › Wisconsin
Kliniske studier for Eggstokkreft i Wisconsin
29 studier for Eggstokkreft søker deltakere på steder i Wisconsin.
Byer i Wisconsin
- Milwaukee17 studier
- Madison13 studier
- Green Bay5 studier
- Manitowoc3 studier
- Sheboygan3 studier
- La Crosse3 studier
- Oshkosh3 studier
- Kenosha3 studier
- Racine3 studier
Offisiell studietekst (engelsk)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- og 42 flere
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Milwaukee
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05877599Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Mayo Clinic Health System - Northwest Wisconsin, Eau Claire
- Mayo Clinic Health System - Southwest Wisconsin, La Crosse
RekruttererObservasjonsstudie
Alder 18 og eldre · Kvinner · Oppdatert 29. sep. 2026 · NCT05051722Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Madison
RekruttererFase 2
Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05489211A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07213804A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- University of Wisconsin - Carbone Cancer Center, Madison
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07213791A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Froedtert & MCW Cancer Center, Milwaukee
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07109726Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Froedtert and The Medical College of Wisconsin, Milwaukee
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 15. sep. 2026 · NCT06915025A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Froedtert & the Medical College of Wisconsin, Milwaukee
RekruttererFase 2
Alder 18 til 99 · Kvinner · Oppdatert 15. sep. 2026 · NCT07023627Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Prohealth Care, Waukesha
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 15. sep. 2026 · NCT07214779Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- University of Wisconsin, Madison
- Medical College of Wisconsin, Milwaukee
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 14. sep. 2026 · NCT06787612ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 45 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06995898Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
- ProHealth Care Inc, Waukesha
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 1. sep. 2026 · NCT07564141Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT06582017Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers
- UW Carbone Cancer Center, Madison
RekruttererObservasjonsstudie
Alder 18 og eldre · Kvinner · Oppdatert 27. aug. 2026 · NCT07125209Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Marshfield Medical Center-Marshfield, Marshfield
- og 6 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT07001748A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Aurora Saint Luke's South Shore, Cudahy
- Aurora Health Care Germantown Health Center, Germantown
- og 20 flere
Rekrutterer
Alder 35 til 50 · Kvinner · Oppdatert 7. aug. 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- og 33 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06580314A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Froedtert and the Medical College of Wisconsin, Milwaukee
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. jul. 2026 · NCT06161025Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 121, Milwaukee
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 16. jul. 2026 · NCT06906341An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
- University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
RekruttererFase 2
Alder 18 til 100 · Kvinner · Oppdatert 13. jul. 2026 · NCT05887609Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Wisconsin, Madison
RekruttererFase 1/2
Alder 18 til 90 · Alle kjønn · Oppdatert 6. jul. 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
- University of Wisconsin Carbone Cancer Center, Madison
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jun. 2026 · NCT05568680Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Froedtert Memorial Lutheran Hospital & Medical College of Wisconsin, Milwaukee
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 16. apr. 2026 · NCT05659381SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.